Recently, MIDN has also been reported to promote proliferation and tumor formation in liver cancer cells,15 and the severity of nonalcoholic fatty liver disease is attenuated in heterozygous Midn knockout (KO) mice.16 Here, MIDN is linked to metabolic dysfunction-associated steatotic liver disease.